Current therapy of acute uncomplicated cystitis
- PMID: 20337730
- DOI: 10.1111/j.1442-2042.2010.02500.x
Current therapy of acute uncomplicated cystitis
Abstract
Acute uncomplicated cystitis (AUC) is one of the most common bacterial urinary tract infections. AUC frequently occurs in young sexually active, as well as postmenopausal, women. According to the guidelines published by the Infectious Diseases Society of America in 1999, the standard antimicrobial regimen for treatment of AUC is 3 days with trimethoprim-sulfamethoxazole (TMP/SMX); however, today the most popular antibiotics are the fluoroquinolones because of the emergence of uropathogens that are resistant to TMP/SMX. Fluoroquinolone resistance is also increasing worldwide, although the resistance rates have not been as high as those for TMP/SMX. Extended-spectrum beta-lactamase (ESBL)-producing strains are another problem because most nosocomial ESBL producers are also resistant to non-beta-lactams, such as the fluoroquinolones. Under such circumstances, 3 days of therapy with fluoroquinolones or 7 days with beta-lactams is recommended for empirical therapy, although these regimens should be re-evaluated in the next decade. Low-dose fluoroquinolones should no longer be used because of the potential for emergence of resistance.
Similar articles
-
Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2006.Int J Antimicrob Agents. 2008 Feb;31 Suppl 1:S15-8. doi: 10.1016/j.ijantimicag.2007.07.043. Epub 2007 Dec 21. Int J Antimicrob Agents. 2008. PMID: 18096373
-
Treatment options for acute uncomplicated cystitis in adults.J Antimicrob Chemother. 2000 Sep;46 Suppl 1:23-7; discussion 63-5. J Antimicrob Chemother. 2000. PMID: 11051620 Review.
-
Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis.J Antimicrob Chemother. 2005 Jul;56(1):243-6. doi: 10.1093/jac/dki169. Epub 2005 May 23. J Antimicrob Chemother. 2005. PMID: 15911548 Clinical Trial.
-
The expanding role of fluoroquinolones.Dis Mon. 2003 Feb;49(2):129-47. doi: 10.1067/mda.2003.12. Dis Mon. 2003. PMID: 12601342 Review.
-
Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection.Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:65-72. doi: 10.1016/s0924-8579(03)00238-3. Int J Antimicrob Agents. 2003. PMID: 14527774 Review.
Cited by
-
A survey of outpatient antibiotic prescribing for cystitis.Dtsch Arztebl Int. 2012 Dec;109(50):878-84. doi: 10.3238/arztebl.2012.0878. Epub 2012 Dec 14. Dtsch Arztebl Int. 2012. PMID: 23293677 Free PMC article.
-
Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.Infection. 2011 Aug;39(4):333-40. doi: 10.1007/s15010-011-0132-6. Epub 2011 Jun 25. Infection. 2011. PMID: 21706226
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
